U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Publisher Name :
Date: 25-Jan-2017
No. of pages: 144
Inquire Before Buying

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021.

In 2016, the cognitive behavioral therapy for insomnia (CBTI) segment is expected to account for the largest share of the market. The other alternative therapies include exercise/yoga, acupuncture, biofeedback, bright light therapy, music therapy, and aroma therapy.

In 2016, the prescription sleep aids segment is expected to account for the largest share of the U.S. insomnia pharmacological treatment market. The launch of Belsomra(Merck & Co., Inc) in 2014 in the U.S. and the anticipated launch of E-2006 (Eisai Co., Ltd.) is expected to drive the growth of the market during the forecast years. However, due to the erosion in branded drugs sales and growing adoption of generics attributed to their low cost and equal efficacy as compared to branded products may hinder the growth of the market. In 2016, the zolpidem segment is expected to account for the largest share of the non-benzodaizepines prescription sleep aids market. However, higher adoption of generic products that are available are cheaper price is negatively affecting the growth of the market.

The over-the-counter sleep aids segment of the U.S. insomnia pharmacological treatment market is expected to grow at the highest CAGR during the forecast period. Reasons attributing to the growth of this market include easier availability, low prices, and publicity regarding the side effects of the prescription sleep aids has also steered the patients towards OTC sleep aid. In 2016, the antihistamines sleep aids segment is expected to hold the largest share of the over-the-counter sleep aids market, whereas, melatonin is expected to grow at the highest CAGR during the forecast period. Growing awareness about the advantages of melatonin such as least amount of side effects, reduces stress levels, and its growing consumption is driving the growth of this segment in the U.S.

Some of the key players offering insomnia treatment (pharmacological)include Eisai, Co. Ltd. (Japan), Merck & Co., Inc. (U.S.), Meda Consumer Healthcare Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi (France), Takeda Pharmaceutical Company Ltd. (Japan), Pernix Therapeutics (U.S.), and Purdue Pharma L.P. (U.S.).

Research Coverage

The market study covers the U.S. insomnia market, by type of treatment, to estimate the overall market size during 2013 to 2021.This report also covers the drivers, restraints, and opportunities of the market along with the competitive landscape of the U.S. insomnia market players.

Reasons to buy this report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:


  • Market Penetration: Comprehensive information regarding products and services offered by the top players in the U.S. insomnia market

  • Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the U.S. insomnia market

  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the U.S. insomnia market

  • Competitive Assessment: In-depth assessment of strategies, products, and pipeline products of the key players in the U.S. insomnia market

U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - Forecasts to 2021

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Key Stakeholders/Influencers

2 Research Methodology
2.1 Market Size Estimation – Non-Pharmacological Treatments Market
2.1.1 Market Breakdown and Data Triangulation
2.1.2 Key Data From Secondary Sources
2.1.3 Key Data From Primary Sources
2.2 Market Size Estimation – Pharmacological Treatments Market
2.2.1 Market Forecast Model
2.2.2 Market Size Estimation
2.2.3 Market Breakdown and Data Triangulation
2.2.4 Key Data From Primary and Secondary Sources
2.3 Research Assumptions

3 Executive Summary

4 Premium Insights
4.1 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
4.2 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
4.3 List of Ongoing Phase-III Clinical Trails for Insomnia
4.4 U.S. Insomnia Market: Consumer Selection Criteria

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Government Support to Control Rising Insomnia Cost
5.2.1.2 OTC Sleep Aids to Drive the Pharmacological Treatment Market Growth
5.2.2 Market Restraints
5.2.2.1 Erosion in Branded Prescription Sleep Aid Sales Due to Growing Adoption of Generics
5.2.2.2 Side Effects of Benzodiazepine and Non-Benzodiazepine Drugs
5.2.2.3 Non Pharmacological Therapies to Restrict the Growth of Drugs Market
5.2.3 Market Opportunities
5.2.3.1 Unmet Need for More Effective and Safe Drugs
5.2.3.2 Presence of Large Insomnia Population Pool

6 Non-Pharmacological Treatment Market
6.1 Introduction
6.1.1 Cognitive Behavioral Therapy for Insomnia (CBTI)
6.1.2 Hypnotherapy
6.1.3 Other Alternative Therapies
6.2 Therapy Recommendation, 2015 (%)
6.3 Qualitative Assessment

7 Pharmacological Treatment Market
7.1 Introduction
7.2 U.S.: Insomnia Pharmacological Treatment Market Size, By Type
7.2.1 U.S.: Prescription Sleep Aids Market Size for Insomnia
7.2.1.1 U.S.: Prescription Sleep Aids Market Size for Insomnia, By Type
7.2.1.1.1 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type
7.2.2 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type

8 Competitive Landscape
8.1 Key Players in the U.S. Insomnia Pharmacological Treatment Market
8.2 Top Available Mobile Applications for Insomnia
8.3 Corporate Strategies Followed Within U.S. Insomnia Market
8.4 Competitive Situations & Trends
8.4.1 Product Launches & Approvals
8.4.2 Collaborations, Agreements and Partnerships
8.4.3 Acquisitions

9 Company Profiles
9.1 Introduction
9.2 Merck & Co., Inc.
9.3 Eisai Co., Ltd.
9.4 Meda Consumer Healthcare, Inc
9.5 Takeda Pharmaceuticals Company Ltd.
9.6 Pfizer Inc.
9.7 Sanofi
9.8 Vanda Pharmaceuticals
9.9 Pernix Therapeutics
9.10 Purdue Pharmaceuticals L.P.

10 Appendix
10.1 Discussion Guide
10.2 Related Reports
10.3 Related Reports
10.4 Knowledgestore Subscription Portal
10.5 MnM Knowledgestore: Snapshot
10.6 RT: Real-Time Market Intelligence
10.7 Disclaimer
10.8 Author Details

List of Tables

Table 1 Key Stakeholders/Influencers for Diagnosed Insomnia Patients
Table 2 Physicians Views About Cognitive Behavioral Therapy for Insomnia (CBTI)
Table 3 Age-Wise Commonly Used/Prescribed Treatments for Each Type of Insomnia
Table 4 List of Ongoing Phase-III Clinical Trails for Insomnia
Table 5 Insomnia Treatment Selection Criteria: Impact Analysis
Table 6 U.S. Insomnia Market, By Non-Pharmacological Treatment (Qualitative Assessment)
Table 7 U.S.: Insomnia Pharmacological Treatment Market Size , By Type, 2013-2021 (USD Million)
Table 8 U.S.: Insomnia Pharmacological Treatment Market Size , By Prescription Sleep Aids, 2013-2021 (USD Million)
Table 9 U.S.: Prescriptions Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 10 U.S.: Non- Benzodiazepine Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 11 U.S.: Over-The-Counter (OTC) Sleep Aids Market Size for Insomnia, By Type, 2013-2021 (USD Million)
Table 12 Key Players in the U.S. Insomnia Pharmacological Treatment Market (2016)
Table 13 Top Available Mobile Applications for Insomnia (2016)
Table 14 Product Launches and Approvals, 2013 –2016
Table 15 Collaborations, Agreements and Partnerships 2013–2016
Table 16 Acquisitions, 2013–2016

List of Figures

Figure 1 Segmentation & Coverage
Figure 2 Prevalence of Insomnia, By Type (2012-2015)
Figure 3 Research Design – Non-Pharmacological Treatments Market
Figure 4 Market Breakdown and Data Triangulation – Non-Pharmacological Treatments Market
Figure 5 Forecasting Model– Pharmacological Treatments Market
Figure 6 Market Size Estimation – Pharmacological Treatments Market
Figure 7 Market Breakdown and Data Triangulation – Pharmacological Treatments Market
Figure 8 Assumptions for the Study
Figure 9 U.S. Insomnia Market Scope
Figure 10 Pharmacological Treatment Market Share, By Type (2014-2021)
Figure 11 U.S. Insomnia Market: Consumer Selection Criteria
Figure 12 U.S. Insomnia Market: Drivers, Restraints, and Opportunities
Figure 13 U.S. Insomnia Market, By Non-Pharmacological Treatment, Therapy Recommendation, 2015 (%)
Figure 14 U.S. Insomnia Pharmacological Treatment Market Segmentation
Figure 15 U.S.: Insomnia Pharmacological Treatment Market, 2013-2021 (USD Million)
Figure 16 Market Share: Pharmacological Treatment Market (2016)
Figure 17 Market Share: Prescription Sleep Aids Market (2016)
Figure 18 U.S. Insomnia Prescription Sleep Aids Market Snapshot
Figure 19 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 20 Market Share: Non-Benzodiazepine Sleep Aids Market (2016)
Figure 21 U.S.: Over-The-Counter (OTC) Sleep Aids Market Snapshot
Figure 22 Battle for Market Share: Product Launches and Approvals—Key Strategies Adopted By Market Players (2013-2016)
Figure 23 Geographic Revenue Mix of Major Players in the U.S. Insomnia Market (2016)
Figure 24 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (2015)
Figure 25 Sanofi: Company Snapshot (2015)
Figure 26 Pfizer Inc: Company Snapshot (2015)
Figure 27 Takeda Pharmaceutical Company Ltd.: Company Snapshot (2015)
Figure 28 Merck & Co., Inc.: Company Snapshot (2015)
Figure 29 Meda Consumer Healthcare Inc.: Company Snapshot (2015)
Figure 30 Eisai Co., Ltd.: Company Snapshot (2015)
Figure 31 Purdue Pharmaceuticals L.P.: Company Snapshot (2015)
Figure 32 Pernix Therapeutics: Company Snapshot (2015)
Figure 33 Vanda Pharmaceuticals: Company Snapshot (2015)

  • Global and Europe Veterinary CT Scanner Market - Analysis and Outlook to 2022
    Published: 22-Aug-2017        Price: US 2960 Onwards        Pages: 116
    This report presents a comprehensive overview of the Veterinary CT Scanner market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Veterinary CT Scanner industry. This report fo......
  • Global Veterinary CT Scanner Detailed Analysis Report 2017-2022
    Published: 22-Aug-2017        Price: US 3250 Onwards        Pages: 111
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Veterinary CT Scanner industry. This report splits Veterinary CT Scanner market By Type, By Animal Type, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022. This report focuses Global market, it ......
  • Global and United States Veterinary CT Scanner In-Depth Research Report 2017-2022
    Published: 22-Aug-2017        Price: US 3190 Onwards        Pages: 111
    The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022. This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Veterinary CT Scanner industry. Major Companies - GE Healthcare (US) - Canon, Inc.(Japan)......
  • 2017-2022 Global and Japan Veterinary CT Scanner Market Analysis Report
    Published: 22-Aug-2017        Price: US 3085 Onwards        Pages: 117
    The global Veterinary CT Scanner market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%. This report, with focus on top players in the global and Japan, studies the Veterinary CT Scanner market's development status and future tr......
  • Global Medical Sterilization Cassettes Market Professional Survey Report 2017
    Published: 21-Aug-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Medical Sterilization Cassettes in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Jakobi Dental Instruments - Allseas - Quick Silver Instrume......
  • Compression Therapy Market by Technique (Static, Dynamic), Product (Compression Garment (Stockings, bandages, Wraps), Compression Braces, Compression Pump), Application (Varicose Vein, Deep Vein Thrombosis, Lymphedema, Leg Ulcer) - Global Forecast to 2022
    Published: 21-Aug-2017        Price: US 5650 Onwards        Pages: 156
    “The compression therapy market projected to grow at a CAGR of 4.7%.” The global compression therapy market is projected to reach USD 3.40 billion by 2022 from USD 2.70 billion in 2017, at a CAGR of 4.7%.The factors driving the growth of the compression therapy market include the growing target patient population, significant sports injuries & accidents across the globe, and technological advancements in the orthopedic industry. However, the lack of un......
  • United States Interventional Cardiology and Peripheral Vascular Devices Market Report 2017
    Published: 21-Aug-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Interventional Cardiology and Peripheral Vascular Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue......
  • United States ECG Leadwires Market Report 2017
    Published: 21-Aug-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States ECG Leadwires market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of EC......
  • Global Sub-acute Care Ventilators Sales Market Report 2017
    Published: 21-Aug-2017        Price: US 4000 Onwards        Pages: 109
    In this report, the global Sub-acute Care Ventilators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Sub-acute Care Ventilators for these regions, from 2012 to 2022 (forecast), covering - United States - China - Euro......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs